Chinese guidelines for diagnosis and treatment of influenza (2011)

Journal of Thoracic Disease

Volumn 3, Issue 4, 2011, Pages 274-289

  Zhong, Nan Shan ^a   Li, Yi Min ^a   Yang, Zi Feng ^a   Wang, Chen ^b   Liu, You Ning ^c   Li, Xing Wang ^d   Shu, Yue Long ^e   Wang, Guang Fa ^f   Gao, Zhan Cheng ^g   Deng, Guo Hua ^h   He, Li Xian ⁱ   Xi, Xiu Ming ^j   Cao, Bin ^k   Shen, Kun Ling ^l   Wu, Hao ^m   Zhou, Ping An ⁿ   Li, Qing Quan ⁿ  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Beijing Institute of Respiratory Medicine   (China)

^c PLA General Hospital   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Institute for Viral Disease Control and Prevention   (China)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

^g PEKING UNIVERSITY   (China)

^h PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

ⁱ FUDAN UNIVERSITY   (China)

^j CAPITAL MEDICAL UNIVERSITY   (China)

^k CAPITAL MEDICAL UNIVERSITY   (China)

^l CAPITAL MEDICAL UNIVERSITY   (China)

^m CAPITAL MEDICAL UNIVERSITY   (China)

ⁿ BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861972035     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2011.10.01     Document Type: Article

References (56)

1. Chinese Medical Association Chinese Society of Respiratory Disease. Draft Guidelines for clinical diagnosis and treatment of influenza. Chin J Tuberc Respir Dis 2002;25:66-8.
2. China Ministry of Health. Interim Technical guidance for prevention and control of avian influenza epidemics. Chin J Countryside Healthcare 2004;11:4-5.
3. China Ministry of Health. Protocols for diagnosis and treatment of influenza A (H1N1) (2009, Ed III) [EB/OL].[2009-10-12]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohyzs/ s3586/200910/43111.htm (accessed: Oct 6, 2011)
4. China Ministry of Health. Protocols for diagnosis and treatment of influenza A (H1N1) (2010). Int J Respir Med 2011;31:81-4.
5. Douglas D, Richman JR, Whitley GF. Clinical Virology. Washington: ASM Press 2009:943-75.
6. Chen JX. Diagnostic virology. Beijing. People's Medical Publishing House 2008;13:115.
7. David M K, Peter M H. Fields Virology 5th Edition. Philadelphia USA: Lippincott Williams and Wilkins 2007:1718.
8. Centers for Disease Control and Prevention (CDC).Estimates of deaths associated with seasonal influenza - United States, 1976-2007.MMWR Morb Mortal Wkly Rep 2010;59:1057-62.
9. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.J Infect Dis 1998;178:53-60.
10. Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus.N Engl J Med 2009;361:115-9.
11. WHO, Clinical management of human infection with pandemic (H1N1) 2009: revised guidance[EB/OL].[2009-11]. http://www.who.int/csr/ resources/publications/swineflu/clinical_management/en/(accessed Oct 6, 2011)
12. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998;101:643-9.
13. L e e N, Wo ng CK, Ch a n PK, Lu n SW, Lu i G, Wo ng B, et al. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin Infect Dis 2007;45:723-31.
14. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-7.
15. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, et al. Avian influenza A (H5N1) infection in humans.N Engl J Med 2005;353:1374-85.
16. Tang JW, Tambyah PA, Lai FY, Lee HK, Lee CK, Loh TP, et al. Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med 2010;170:861-7.
17. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med 2008;121:258-64.
18. WHO. Clinical features of severe cases of pandemic influenza. [EB/OL]. [2010-10-2]. http://www.who.int/csr/disease/swineflu/notes/h1n1_ clinical_features_20091016/zh/ (accessed Oct 6, 2011)
19. Perez-Padilla R, de la Rosa-Zamboni D, Ponce De Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico.N Engl J Med 2009;361:680-9.
20. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351:467-71.
21. Hui DS. Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection. Respirology 2008;13:S10-3.
22. Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009;49:279-90.
23. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-32.
24. Riquelme R, Torres A, Rioseco ML, Ewig S, Cillóniz C, Riquelme M, et al. Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic. Eur Respir J 2011;38:106-11.
25. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenzalike illness: an observational study. Lancet 2001;358:1410-6.
26. Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome.N Engl J Med 2003;348:1967-76.
27. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, et al. Avian influenza A (H5N1) in 10 patients in Vietnam.N Engl J Med 2004;350:1179-88.
28. Falsey AR, Walsh EE, Hayden FG. Rhinovirus and coronavirus infectionassociated hospitalizations among older adults.J Infect Dis 2002;185:1338-41.
29. Cao B, Ren LL, Zhao F, Gonzalez R, Song SF, Bai L, et al. Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. Eur J Clin Microbiol Infect Dis 2010;29:1443-8.
30. Pandemic Influenza Experts Advisory Committee(Japan). Guideline for Antiviral Drugs[EB/OL].[2007-03-26]. http://www.mhlw.go.jp/bunya/ kenkou/kekkaku-kansenshou04/pdf/09-e10.pdf. (Accessed Oct 6, 2011)
31. Wright PF, Kirkland KB, Modlin JF. When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia.N Engl J Med 2009;361:e112.
32. Antibiotic Therapy Guidance Clinical Care Advasory Group. British Columbia's H1N1 pandemic influenza response plan(2009) [EB/OL]. [2009-10-19]. http://www.health.gov.bc.ca/pandemic/response/pdf/ testing_guidelines_h1n1.pdf (accessed Oct 6, 2011)
33. McCracken J. Should noninvasive ventilation be considered a high-risk procedure during an epidemic? CMAJ 2009;181:663-4.
34. World Health Organization. WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza Viruses[EB/OL].[2010-02]. http://www.who.int/csr/resources/ publications/swineflu/h1n1_use_antivirals_20090820/en/index.html (accessed Oct 6, 2011)
35. Communicable Diseases Network Australia (CDNA). A Practical Guide to assist in the Prevention and Management of Influenza Outbreaks in Residential Care Facilities in Australia[EB/OL].[2010-12]. http:// www.health.qld.gov.au/ph/documents/cdb/influenzaoutbreakmana.pdf (accessed Oct 6, 2011)
36. National Institute for Health and Clinical Excellence. Amantadine, oseltamivir and zanamivir for the treatment of influenza[EB/OL].[2010-09]. http://www.nice.org.uk/nicemedia/pdf/TA158PublicInfo.pdf (accessed Oct 6, 2011)
37. Han L, Xie JX, Yin JH, et al. Analysis of oseltamivir-resistant H275Y mutation in a novel A/H1N1 influenza virus strain. Medical Journal of Chinese People's Liberation Army 2009;34:1403-7.
38. Committee on Infectious Diseases. Policy statement-recommendations for the prevention and treatment of influenza in children, 2009-2010. Pediatrics 2009;124:1216-26.
39. Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant D. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ 2009;339:b3172.
40. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302:1872-9.
41. Miller RR 3rd, Markewitz BA, Rolfs RT, Brown SM, Dascomb KK, Grissom CK, et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest 2010;137:752-8.
42. Chinese Medical Association Chinese Society of Critical Care Medicine. Guidelines on hemodynamic monitoring and support for severe infection and septic shock in adults. Chinese Journal of Emergency Medicine 2007;16:121-6.
43. Chinese Medical Association Chinese Society of Critical Care Medicine. Guidelines on diagnosis and treatment of acute lung injury and acute respiratory distress syndrome (2006). Chinese Journal of Emergency Medicine 2007;16:343-9.
44. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
45. Davies A, Jones D, Bailey M, Beca J, Bellomo R, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, JAMA 2009;302:1888-95.
46. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351-63.
47. Mitchell MD, Mikkelsen ME, Umscheid CA, Lee I, Fuchs BD, Halpern SD. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med 2010;38:1398-404.
48. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979;242:2193-6.
49. Lefrak EA, Stevens PM, Pitha J, Balsinger E, Noon GP, Mayor HD. Extracorporeal membrane oxygenation for fulminant influenza pneumonia. Chest 1974;66:385-8.
50. Topalian S, Ginsberg F, Parrillo JE. Cardiogenic shock. Crit Care Med 2008;36:S66-74.
51. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection [published online ahead of print Nov 24,2010]. Intensive Care Med[2010-9-24].http://www. springerlink.com/content/rv1100r574pq3188/. (accessed Oct 6, 2011)
52. Xi ZQ, Zhou JZ, Mei JQ. Effect of Shufeng Jiedu Capsule on the fever caused by viral upper respiratory tract infection: a report of 130 cases. Journal of Traditional Chinese Medicine 2010;51:426-7.
53. Liu Y, Cui XL, Shi H, Jin YH, Gao YJ, Shi YJ, et al. Study on Pharmacodynamic Trial in Vivo of Shufengjiedu Capsule on Prevention and Treatment of Influenza. World Journal of Integrated Traditional and Western Medicine 2010;5:35-9.
54. Yang LB, Ji ZH, Wang BQ. Clinical observation of the therapeutic effect of Lianhuaqingwen capsule on 280 cases of influenza. Chinese Journal of Difficult and Complicated Cases 2005;4:276-8.
55. Chang J, Li ZQ, Wan MH, Zhang RM, Zhang Y, Wang L, et al. A Double-Blind Randomized Controlled Trial of Jinlianqingre Capsule in the Treatment of Acute Upper Respiratory Tract Infection (External Wind-heat Syndrome). Chinese Journal of Evidence-Based Medicine 2005;5:593-8.
56. Chinese Center for Disease Control and Prevention. Technical recommendations for preventive vaccination against influenza (2010-2011) [EB/OL].[2010-11-17]. http://www.chinacdc.cn/n272442/n272530/ n3479265/n3479308/40232.html (accessed Oct 6, 2011)